Zhang M - Search Results

1

High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.

Yu J, Jiang L, Zhao L, Yang X, Wang X, Yang D, Zhuo M, Chen H, Huang W, Zhu Z, Zhang M, Song Y, Li Q, Ma Z, Wang Q, Qu Y, Yu R, Yu H, Zhao J, Shi A; Trial Management Group. Yu J, et al. Among authors: zhang m. Lancet Respir Med. 2024 Oct;12(10):799-809. doi: 10.1016/S2213-2600(24)00189-9. Epub 2024 Aug 12. Lancet Respir Med. 2024. PMID: 39146944 Clinical Trial.

2

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial.

Zhong H, Sun S, Chen J, Wang Z, Zhao Y, Zhang G, Chen G, Zhou M, Zhou J, Du Y, Wu L, Xu Z, Mei X, Zhang W, He J, Cui J, Zhang Z, Luo H, Liu W, Sun M, Wu J, Shen Y, Zhang S, Yang N, Wang M, Lu J, Li K, Yao W, Sun Q, Yue H, Wang L, Ye S, Li B, Zhuang X, Pan Y, Zhang M, Shu Y, He Z, Pan L, Ling Y, Liu S, Zhang Q, Jiao S, Han B. Zhong H, et al. Among authors: zhang m, zhang s, zhang q, zhang g, zhang w, zhang z. Lancet Respir Med. 2024 May;12(5):355-365. doi: 10.1016/S2213-2600(23)00431-9. Epub 2024 Jan 31. Lancet Respir Med. 2024. PMID: 38309287 Clinical Trial.

3

m⁶A regulators featured by tumor immune microenvironment landscapes and correlated with immunotherapy in non-small cell lung cancer (NSCLC).

Yuan B, Qin H, Zhang J, Zhang M, Yang Y, Teng X, Yu H, Huang W, Wang Y. Yuan B, et al. Among authors: zhang m, zhang j. Front Oncol. 2022 Dec 16;12:1087753. doi: 10.3389/fonc.2022.1087753. eCollection 2022. Front Oncol. 2022. PMID: 36591468 Free PMC article.

4

Identifying key transcription factors and immune infiltration in non-small-cell lung cancer using weighted correlation network and Cox regression analyses.

Zhang J, Wang Y, Yuan B, Qin H, Wang Y, Yu H, Teng X, Yang Y, Zou J, Zhang M, Huang W, Wang Y. Zhang J, et al. Among authors: zhang m. Front Oncol. 2023 May 1;13:1112020. doi: 10.3389/fonc.2023.1112020. eCollection 2023. Front Oncol. 2023. PMID: 37197420 Free PMC article.

5

A preliminary study identifies early postoperative lung volume changes in patients with non-small cell lung cancer following video-assisted thoracic surgery using CT volumetry.

Du X, Li H, Liu L, Zhang M, Tang Z, Zhang J, Lin P, Xie H, Chen C. Du X, et al. Among authors: zhang m, zhang j. Mol Clin Oncol. 2021 Jun;14(6):124. doi: 10.3892/mco.2021.2286. Epub 2021 Apr 22. Mol Clin Oncol. 2021. PMID: 33936597 Free PMC article.

6

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy.

Zhang M, Zhu L, Liang S, Mao Z, Li X, Yang L, Yang Y, Wang K, Wang P, Chen W. Zhang M, et al. Front Oncol. 2024 Jun 25;14:1411436. doi: 10.3389/fonc.2024.1411436. eCollection 2024. Front Oncol. 2024. PMID: 38983930 Free PMC article.

7

Methylation of KRAS by SETD7 promotes KRAS degradation in non-small cell lung cancer.

Chiang CY, Fan S, Zheng H, Guo W, Zheng Z, Sun Y, Zhong C, Zeng J, Li S, Zhang M, Xiao T, Zheng D. Chiang CY, et al. Among authors: zhang m. Cell Rep. 2023 Sep 26;42(9):113003. doi: 10.1016/j.celrep.2023.113003. Epub 2023 Sep 8. Cell Rep. 2023. PMID: 37682707 Free article.

8

Head-to-head comparison of ¹⁸F-FDG PET/CT and ¹⁸F-FDG PET/MRI for lymph node metastasis staging in non-small cell lung cancer: a meta-analysis.

Zhang M, Liu Z, Yuan Y, Yang W, Cao X, Ma M, Han B. Zhang M, et al. Diagn Interv Radiol. 2024 Mar 6;30(2):99-106. doi: 10.4274/dir.2023.232280. Epub 2024 Jan 31. Diagn Interv Radiol. 2024. PMID: 38291975 Free PMC article.

9

Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer.

Bissett D, O'Byrne KJ, von Pawel J, Gatzemeier U, Price A, Nicolson M, Mercier R, Mazabel E, Penning C, Zhang MH, Collier MA, Shepherd FA. Bissett D, et al. Among authors: zhang mh. J Clin Oncol. 2005 Feb 1;23(4):842-9. doi: 10.1200/JCO.2005.03.170. J Clin Oncol. 2005. PMID: 15681529 Clinical Trial.

10

Lambert-Eaton myasthenic syndrome in patients with small cell lung cancer: Report of five cases.

Hao Y, Hu J, Zhang Y, Liu W, Lu S, Zhang M. Hao Y, et al. Among authors: zhang m, zhang y. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C95-6. doi: 10.4103/0973-1482.163853. J Cancer Res Ther. 2015. PMID: 26323934 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,520 results

Search Page

Filters